Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy
1 clinical trials · Condition
◉ Watch Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy
| Record | Firm | Date |
|---|---|---|
| TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy (NCT07223203) | Alnylam Pharmaceuticals | 2025-12-12 |
Track Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy automatically
Every clearance here is in the API, with alerts when new ones post.